Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) announced that it has partnered with Prasco, LLC to introduce an Authorized Generic version of Testim (testosterone gel). Prasco has product inventory available and has commenced shipping product. Testim and its Authorized Generic version are testosterone gels approved by the U.S. Food and Drug Administration to treat adult males who have low or no testosterone. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) net profit margin is -17.50% and weekly performance is -2.80%. On last trading day company shares ended up $21.44. Analysts mean target price for the company is $27.00. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) distance from 50-day simple moving average is -9.09%.
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) announced the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology. Under the terms of the agreement, Roche will pay Genia’s shareholders USD 125 million in cash. In addition to this payment from Roche, Genia’s shareholders may receive up to USD 225 million in contingent payments depending on the achievement of certain milestones. Genia’s proprietary technology is expected to reduce the price of sequencing while increasing speed and sensitivity. Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) shares fell -1.18% in last trading session and ended the day on $36.93. RHHBY Gross Margin is 72.80% and its return on assets is -6.40%. Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) quarterly performance is -28.61%.
Celgene Corporation (NASDAQ:CELG) is heading for partnership once again under a new venture with a prestigious healthcare firm Patrick Soon-Shiong. Celgene Corporation will announce to invest $25 million in NantHealth, which is a technologically advanced healthcare company established by Soon-Shiong. An announcement is expected by next Tuesday. Celgene Corporation (NASDAQ:CELG) shares moved down -0.14% in last trading session and was closed at $159.99, while trading in range of $159.20-$161.00. Celgene Corporation (NASDAQ:CELG) year to date -performance is -5.31%.
Amgen, Inc. (NASDAQ:AMGN) the world’s largest biotechnology company, on Monday named manufacturing and auto industry veteran David Meline as chief financial officer. Amgen, Inc. (NASDAQ:AMGN) ended the last trading day at $116.03. Company weekly volatility is calculated as 1.30% and price to cash ratio as 4.44. Amgen, Inc. (NASDAQ:AMGN) showed a negative weekly performance of -1.52%.
Bayer AG (ADR) (OTCMKTS:BAYRY) Chief Executive Officer Marijn Dekkers will step down at the end of 2016, setting up a contest for the top job at one of Germany’s largest companies. Bayer AG (ADR) (OTCMKTS:BAYRY) On last trading day company shares ended up $140.45.